Advertisement
Canada markets open in 42 minutes
  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CAD/USD

    0.7325
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    79.71
    +0.45 (+0.57%)
     
  • Bitcoin CAD

    86,323.62
    +2,399.09 (+2.86%)
     
  • CMC Crypto 200

    1,308.10
    -49.91 (-3.67%)
     
  • GOLD FUTURES

    2,373.00
    +32.70 (+1.40%)
     
  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     
  • 10-Yr Bond

    4.4790
    +0.0300 (+0.67%)
     
  • NASDAQ futures

    18,274.75
    +60.25 (+0.33%)
     
  • VOLATILITY

    12.77
    +0.08 (+0.63%)
     
  • FTSE

    8,447.33
    +65.98 (+0.79%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6798
    +0.0020 (+0.30%)
     

What Citron Research Has to Say about Aphria

What Citron Research Has to Say about Aphria

Last week was a brutal week for Aphria (APHA) (APHQF). Aphria’s troubles began last Monday when Gabriel Grego of Quintessential Capital Management called the stock “worthless” and explained in detail why he believes the company destroyed shareholder value. Aphria fought back and appointed a special committee that consists of independent directors who will be tasked with reviewing the allegations.